Human protein tyrosine phosphatase-sigma: alternative splicing and inhibition by bisphosphonates

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
N EndoA Schmidt

Abstract

Two forms of the transmembrane human protein tyrosine phosphatase (PTP sigma), generated by alternative splicing, were identified by cDNA cloning and Northern hybridization with selective cDNA probes. The larger form of PTP sigma is expressed in various human tissues, human osteosarcoma, and rat tibia. The hPTP sigma cDNA codes for a protein of 1911 amino acid residues and is composed of a cytoplasmic region with two PTP domains and an extracellular region that can be organized into three tandem repeats of immunoglobulin-like domains and eight tandem repeats of fibronectin type III-like domains. In the brain, the major transcript of PTP sigma is an alternatively spliced mRNA, in which the coding region for the fibronectin type III-like domains number four to seven are spliced out, thus coding for a protein of 1502 amino acid residues similar to the rat PTP sigma and rat PTP-NE3. Using in situ hybridization, we assigned hPTP sigma to chromosome 6, arm 6q and band 6q15. The bacterial-expressed hPTP sigma exhibits PTPase activity that was inhibited by orthovanadate (IC50 = 0.02 microM) and by two bisphosphonates used for the treatment of bone diseases, alendronate (ALN) (IC50 = 0.5 microM) and etidronate (IC50 = 0.2 microM). In qu...Continue Reading

References

Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M X GuP W Majerus
Apr 20, 1990·Cell·A Ullrich, J Schlessinger
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R J MatthewsM L Thomas
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J SapJ Schlessinger
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R KaplanJ Schlessinger
Dec 1, 1989·Analytical Biochemistry·G G NemethM E Bolander
Jun 1, 1989·Immunology Today·D R Alexander, D A Cantrell
Dec 1, 1989·Trends in Biochemical Sciences·N K Tonks, H Charbonneau
Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G C OwensB A Cunningham
Sep 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·B A MurrayB A Cunningham
Jul 1, 1983·Endocrinology·N S Krieger, A H Tashjian
Jun 18, 1993·Cell·J A Cooper, B Howell
Feb 1, 1995·Molecular and Cellular Biology·P BellostaC Basilico
Aug 1, 1993·Annals of Medicine·G A Rodan, R Balena
Jan 1, 1994·Molecular and Cellular Biology·J SapJ Schlessinger
May 1, 1993·The Journal of Clinical Investigation·M SahniT J Martin
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·A SchmidtG A Rodan

❮ Previous
Next ❯

Citations

Sep 27, 2003·European Journal of Pharmacology·Fumiaki ItohHiroshi Kogo
Sep 19, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T HiragaH Ozawa
Oct 7, 2003·Molecular Biology of the Cell·Riccardo ChiusaroliAri Elson
May 23, 1998·Annual Review of Pharmacology and Toxicology·G A Rodan
Jun 15, 1996·The Journal of Clinical Investigation·G A Rodan, H A Fleisch
Oct 5, 2018·Expert Review of Hematology·Nikolaos KanelliasMeletios Athanasios Dimopoulos
Apr 27, 2019·Expert Opinion on Therapeutic Patents·Sarah A Holstein
Oct 6, 1999·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R G RussellH A Fleisch
Oct 21, 2004·Anti-cancer Drugs·Marta VorotnjakClaudia Lanvers-Kaminsky
Jan 28, 2005·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Mélanie J ChagnonMichel L Tremblay
Jul 13, 2006·Annals of the New York Academy of Sciences·R Graham G Russell
Jul 5, 2008·Expert Review of Molecular Diagnostics·Aleixo Muise, Daniela Rotin
Sep 5, 1997·The Journal of Biological Chemistry·K SkoreyQ Wang
Mar 4, 2000·Pharmazie in unserer Zeit·G K Scriba
Feb 20, 2003·Current Rheumatology Reports·Alfred A Reszka, Gideon A Rodan
Dec 13, 2006·Cancer Metastasis Reviews·Muzaffer Cicek, Merry Jo Oursler
Mar 12, 1998·Endocrine Reviews·H Fleisch
Oct 6, 1997·Biochemical Pharmacology·E E OpasA Schmidt
May 13, 1999·Bone·M J RogersR G Russell
Jul 7, 2007·Current Biology : CB·Aleixo M MuiseDaniela Rotin
Dec 21, 2010·Archives of Biochemistry and Biophysics·Susana MorelliGraciela Santillan
Mar 3, 2007·Pediatrics·R Graham G Russell
Jul 17, 2012·Archives of Oral Biology·Hulya TokerKaya Eren

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.